Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020

SELL
$105.46 - $144.13 $1.77 Million - $2.42 Million
-16,778 Closed
0 $0
Q2 2020

Aug 04, 2020

SELL
$95.68 - $121.88 $118,643 - $151,131
-1,240 Reduced 6.88%
16,778 $1.85 Million
Q1 2020

Apr 29, 2020

SELL
$87.74 - $152.74 $30,709 - $53,459
-350 Reduced 1.91%
18,018 $1.8 Million
Q4 2019

Jan 29, 2020

SELL
$117.65 - $153.73 $876,492 - $1.15 Million
-7,450 Reduced 28.86%
18,368 $2.74 Million
Q3 2019

Oct 28, 2019

SELL
$125.18 - $143.24 $261,876 - $299,658
-2,092 Reduced 7.5%
25,818 $3.31 Million
Q2 2019

Aug 01, 2019

BUY
$125.55 - $144.48 $3.5 Million - $4.03 Million
27,910 New
27,910 $3.98 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.86B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Twin Capital Management Inc Portfolio

Follow Twin Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.